Raymond James raised the firm's price target on Allstate to $300 from $260 and keeps a Strong Buy rating on the shares. The firm expects a strong ROE profile supported by continued market share gains, disciplined pricing, and incremental expense efficiencies driven by Transformative Growth initiatives and technology investments, the analyst tells investors in a research note.
